Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis

Abstract Background Inflammatory osteolysis, a major complication of total joint replacement surgery, can cause prosthesis failure and necessitate revision surgery. Macrophages are key effector immune cells in inflammatory responses, but excessive M1-polarization of dysfunctional macrophages leads t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cheng Ding, Chuang Yang, Tao Cheng, Xingyan Wang, Qiaojie Wang, Renke He, Shang Sang, Kechao Zhu, Dongdong Xu, Jiaxing Wang, Xijian Liu, Xianlong Zhang
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/9b1124ab7b22439f9b6250b3c632546b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9b1124ab7b22439f9b6250b3c632546b
record_format dspace
spelling oai:doaj.org-article:9b1124ab7b22439f9b6250b3c632546b2021-11-28T12:26:41ZMacrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis10.1186/s12951-021-01128-41477-3155https://doaj.org/article/9b1124ab7b22439f9b6250b3c632546b2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12951-021-01128-4https://doaj.org/toc/1477-3155Abstract Background Inflammatory osteolysis, a major complication of total joint replacement surgery, can cause prosthesis failure and necessitate revision surgery. Macrophages are key effector immune cells in inflammatory responses, but excessive M1-polarization of dysfunctional macrophages leads to the secretion of proinflammatory cytokines and severe loss of bone tissue. Here, we report the development of macrophage-biomimetic porous SiO2-coated ultrasmall Se particles (porous Se@SiO2 nanospheres) to manage inflammatory osteolysis. Results Macrophage membrane-coated porous Se@SiO2 nanospheres(M-Se@SiO2) attenuated lipopolysaccharide (LPS)-induced inflammatory osteolysis via a dual-immunomodulatory effect. As macrophage membrane decoys, these nanoparticles reduced endotoxin levels and neutralized proinflammatory cytokines. Moreover, the release of Se could induce macrophage polarization toward the anti-inflammatory M2-phenotype. These effects were mediated via the inhibition of p65, p38, and extracellular signal-regulated kinase (ERK) signaling. Additionally, the immune environment created by M-Se@SiO2 reduced the inhibition of osteogenic differentiation caused by proinflammation cytokines, as confirmed through in vitro and in vivo experiments. Conclusion Our findings suggest that M-Se@SiO2 have an immunomodulatory role in LPS-induced inflammation and bone remodeling, which demonstrates that M-Se@SiO2 are a promising engineered nanoplatform for the treatment of osteolysis occurring after arthroplasty. Graphical AbstractCheng DingChuang YangTao ChengXingyan WangQiaojie WangRenke HeShang SangKechao ZhuDongdong XuJiaxing WangXijian LiuXianlong ZhangBMCarticleBiomimetic nanoparticlePorous Se@SiO2 nanospheresMacrophage polarizationOsteolysisImmunomodulationBiotechnologyTP248.13-248.65Medical technologyR855-855.5ENJournal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biomimetic nanoparticle
Porous Se@SiO2 nanospheres
Macrophage polarization
Osteolysis
Immunomodulation
Biotechnology
TP248.13-248.65
Medical technology
R855-855.5
spellingShingle Biomimetic nanoparticle
Porous Se@SiO2 nanospheres
Macrophage polarization
Osteolysis
Immunomodulation
Biotechnology
TP248.13-248.65
Medical technology
R855-855.5
Cheng Ding
Chuang Yang
Tao Cheng
Xingyan Wang
Qiaojie Wang
Renke He
Shang Sang
Kechao Zhu
Dongdong Xu
Jiaxing Wang
Xijian Liu
Xianlong Zhang
Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis
description Abstract Background Inflammatory osteolysis, a major complication of total joint replacement surgery, can cause prosthesis failure and necessitate revision surgery. Macrophages are key effector immune cells in inflammatory responses, but excessive M1-polarization of dysfunctional macrophages leads to the secretion of proinflammatory cytokines and severe loss of bone tissue. Here, we report the development of macrophage-biomimetic porous SiO2-coated ultrasmall Se particles (porous Se@SiO2 nanospheres) to manage inflammatory osteolysis. Results Macrophage membrane-coated porous Se@SiO2 nanospheres(M-Se@SiO2) attenuated lipopolysaccharide (LPS)-induced inflammatory osteolysis via a dual-immunomodulatory effect. As macrophage membrane decoys, these nanoparticles reduced endotoxin levels and neutralized proinflammatory cytokines. Moreover, the release of Se could induce macrophage polarization toward the anti-inflammatory M2-phenotype. These effects were mediated via the inhibition of p65, p38, and extracellular signal-regulated kinase (ERK) signaling. Additionally, the immune environment created by M-Se@SiO2 reduced the inhibition of osteogenic differentiation caused by proinflammation cytokines, as confirmed through in vitro and in vivo experiments. Conclusion Our findings suggest that M-Se@SiO2 have an immunomodulatory role in LPS-induced inflammation and bone remodeling, which demonstrates that M-Se@SiO2 are a promising engineered nanoplatform for the treatment of osteolysis occurring after arthroplasty. Graphical Abstract
format article
author Cheng Ding
Chuang Yang
Tao Cheng
Xingyan Wang
Qiaojie Wang
Renke He
Shang Sang
Kechao Zhu
Dongdong Xu
Jiaxing Wang
Xijian Liu
Xianlong Zhang
author_facet Cheng Ding
Chuang Yang
Tao Cheng
Xingyan Wang
Qiaojie Wang
Renke He
Shang Sang
Kechao Zhu
Dongdong Xu
Jiaxing Wang
Xijian Liu
Xianlong Zhang
author_sort Cheng Ding
title Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis
title_short Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis
title_full Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis
title_fullStr Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis
title_full_unstemmed Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis
title_sort macrophage-biomimetic porous se@sio2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis
publisher BMC
publishDate 2021
url https://doaj.org/article/9b1124ab7b22439f9b6250b3c632546b
work_keys_str_mv AT chengding macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis
AT chuangyang macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis
AT taocheng macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis
AT xingyanwang macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis
AT qiaojiewang macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis
AT renkehe macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis
AT shangsang macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis
AT kechaozhu macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis
AT dongdongxu macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis
AT jiaxingwang macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis
AT xijianliu macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis
AT xianlongzhang macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis
_version_ 1718407972051222528